Conference News | tctmd.com

News Conference News EuroPCR 2012

TAVR Studies Tease Out Influences on Clinical Outcome

By Caitlin E. Cox

May 18, 2012

News Conference News EuroPCR 2012

FAME II: FFR Pinpoints Stable CAD Patients Who Need PCI in Addition to Medical Therapy

By Caitlin E. Cox

May 15, 2012

News Conference News ACC 2012

Daily Rivaroxaban as Effective as Enoxaparin for Pulmonary Embolism

By L.A. McKeown

March 26, 2012

News Conference News ACC 2012

RESOLUTE: Zotarolimus-Eluting Stent Fares Well at 2 Years

March 26, 2012

News Conference News ACC 2012

New Antiplatelet Agent Vorapaxar Shows Promise, But At the Expense of Bleeding

By L.A. McKeown

March 24, 2012

News Conference News EuroPCR 2012

Biolimus-Eluting Stents Perform Well in STEMI, Unselected Populations

May 15, 2012

News Conference News ACC 2012

Three Months of Antiplatelet Therapy with Endeavor Equal to 1 Year with Other DES

March 24, 2012

News Conference News ACC 2012

PARTNER: TAVR Remains as Effective as Surgery at 2 Years

March 26, 2012

News Conference News ACC 2012

Adjunctive Cilostazol Noninferior to Double-Dose Clopidogrel in All-Comer PCI Trial

By L.A. McKeown

March 25, 2012

News Conference News EuroPCR 2012

Mixed Results Shown with Adenosine-Free Pressure Measurement vs. FFR

May 16, 2012

Subscribe to Conference News

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.